DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR EPINASTINE HYDROCHLORIDE

« Back to Dashboard

Clinical Trials for Epinastine Hydrochloride

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00407927	A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis	Completed	Merck Sharp & Dohme Corp.	Phase 2	The purpose of this trial is to determine the safety, efficacy and tolerability of two doses of the study drug compared to placebo for the treatment of subjects with seasonal allergic rhinitis.
NCT00489398	Comparison of CL Wear Between Two Allergy Drops	Withdrawn	Merck Sharp & Dohme Corp.	Phase 4	Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00489398	Comparison of CL Wear Between Two Allergy Drops	Withdrawn	Hom, Milton M., OD, FAAO	Phase 4	Comparison of two allergy drops for enhancing comfort and performance of contact lens wear
NCT00564421	Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)	Completed	Merck Sharp & Dohme Corp.	Phase 3	The purpose of this study is to determine the safety and efficacy of epinastine nasal spray compared to placebo for the treatment of subjects with seasonal allergic rhinitis
NCT01382654	Two Formulations and Concentrations of Epinastine Nasal Spray Versus Azelastine Nasal Solution for Allergic Rhinitis	Completed	Merck Sharp & Dohme Corp.	Phase 2	The objectives of this study were to: - Examine the tolerability of two formulations and two dose concentrations of epinastine. - Select formulation(s) of epinastine for future studies by evaluating the individual sensory attribute scores of the Nasal Spray Evaluation Questionnaire (NSEQ) collected after each study drug administration and the subject preference ranking assessed at the completion of the study. - Compare the preference of two formulations and two dose concentrations of epinastine compared to azelastine following a single dose of each in a randomized, double-blind, two-cohort, three-period crossover design.

Clinical Trial Conditions for Epinastine Hydrochloride

Condition Name

Condition Name for Epinastine Hydrochloride
Intervention	Trials
Rhinitis, Allergic, Perennial	4
Healthy	3
Allergic Conjunctivitis	2
Seasonal Allergic Rhinitis	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Epinastine Hydrochloride
Intervention	Trials
Rhinitis, Allergic	7
Rhinitis	7
Rhinitis, Allergic, Perennial	4
Conjunctivitis, Allergic	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Epinastine Hydrochloride

Trials by Country

Trials by Country for Epinastine Hydrochloride
Location	Trials
United States	1
United Kingdom	1

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Epinastine Hydrochloride
Location	Trials
Texas	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Epinastine Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Epinastine Hydrochloride
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	4
Phase 2	2

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Epinastine Hydrochloride
Clinical Trial Phase	Trials
Completed	14
Withdrawn	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Epinastine Hydrochloride

Sponsor Name

Sponsor Name for Epinastine Hydrochloride
Sponsor	Trials
Boehringer Ingelheim	9
Merck Sharp & Dohme Corp.	4
Hom, Milton M., OD, FAAO	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Epinastine Hydrochloride
Sponsor	Trials
Industry	14
Other	3

Export unavailable in trial.
Subscribe for complete access.